Profil
Nickols Lee Huang is the founder of Virun, Inc. He held the title of President at the company, but is no longer active in that role.
Aktive Positionen von Nickols Lee Huang
Unternehmen | Position | Beginn |
---|---|---|
Virun, Inc.
Virun, Inc. BiotechnologyHealth Technology Virun, Inc. develops effective drug delivery and food and beverage ingredients. Its products include OmegaH2O and Coenzyme Clear. The firm operates through three segments: food and beverage ingredient manufacturing, consumer product development and pharmaceutical drug delivery. The foods and beverage ingredient manufacturing segment produces novel food and beverage concentrates stemming from a patented portfolio. The consumer product development segment develops novel and patented consumer products that allow substantiated health claims. The pharmaceutical drug delivery segment utilizes its patented technologies to improve the pharmacokinetics (delivery) and dynamics (efficacy) of peptides and compounds that have poor oral bioavailability or over-all functionality. The company was founded in 2003 by Philip James Bromley and is headquartered in Walnut, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Virun, Inc.
Virun, Inc. BiotechnologyHealth Technology Virun, Inc. develops effective drug delivery and food and beverage ingredients. Its products include OmegaH2O and Coenzyme Clear. The firm operates through three segments: food and beverage ingredient manufacturing, consumer product development and pharmaceutical drug delivery. The foods and beverage ingredient manufacturing segment produces novel food and beverage concentrates stemming from a patented portfolio. The consumer product development segment develops novel and patented consumer products that allow substantiated health claims. The pharmaceutical drug delivery segment utilizes its patented technologies to improve the pharmacokinetics (delivery) and dynamics (efficacy) of peptides and compounds that have poor oral bioavailability or over-all functionality. The company was founded in 2003 by Philip James Bromley and is headquartered in Walnut, CA. | Health Technology |